PEN: Penumbra Medical P/E multiplikatori

Penumbra, Inc. (PEN) kompaniyasining P/E dinamikasi, uning noyob tromb oluvchi usullari tufayli neyroxirurgiya sohasidagi yetakchiligi bilan qo'llab-quvvatlangan o'sish tendentsiyasini namoyish etmoqda. Biroq, 81.20 qiymati tartibga soluvchi kechikishlar xavflari va klinikalarning narxlar bo'yicha bosimini hisobga olgan real vaqt rejimidagi bahodir. Shu bilan birga, trombektomiya tizimlari hisobiga tushumning o'sishi daromadlilikni oshirmoqda, garchi yuqori bozor bahosi yanada kengayish uchun yangi katalizatorlarni talab qilsa-da.

PEN: Penumbra P/E multiplikatori 04.07.2022 - 14.11.2026

Penumbra Corp (PEN) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:

Birja narxi penumbrainc.com|PEN - Konsensus maqsadli narx

- bozor kapitallashuvi haqida ma'lumot:

Bozor kapitallashuvi Penumbra, Inc.|PEN - Kompaniyani butunlay sotib olishdagi haqiqiy narx

- kompaniyaning balans qiymati tafsilotlari:

Aksiyaning balans narxi Penumbra|PEN - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi penumbrainc.com|PEN - Kompaniyaning umumiy aktivlari

- qarz majburiyatlari va likvidlik statistikasi:

Umumiy qarzning xususiy kapitalga nisbati Penumbra, Inc.|PEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Penumbra Medical|PEN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Penumbra, Inc.|PEN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Penumbra|Shoshilinch likvidlik koeffitsiyenti penumbrainc.com

- foyda va qiymat multiplikatorlari haqida ma'lumot:

PEN - Sof foyda|Kompaniya foydasi prognozi Penumbra, Inc.|PEN - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Penumbra Inc|PEN - PEG multiplikatori|EV/EBITDA multiplikatori Penumbra, Inc.|PEN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Penumbra|PEN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi penumbrainc.com|PEN - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Penumbra, Inc.

- kompaniyaning sotuvlari va tushumi statistikasi:

PEN - Kompaniya daromadi|Kompaniya savdosi prognozi penumbrainc.com|PEN - Kapitalizatsiyaning daromadga nisbati|Forvard P/S multiplikatori Penumbra, Inc.

Kompaniyaning har tomonlama tahlili:PEN penumbrainc.com

Konservativ investor P/E koeffitsiyentini kelajakdagi pul oqimi uchun bozorning haddan tashqari to'lov qilganligining ko'rsatkichi sifatida baholaydi. Penumbra, Inc. (PEN) uchun yuqori baholash neyrovaskulyar jarrohlik uchun aniqlik kateterlarini ishlab chiqarishda yetakchi maqomi bilan oqlanadi. Ushbu foyda nisbatidagi narx koeffitsiyenti joriy aksiya narxi va aksiya uchun sof foyda o'rtasidagi bog'liqlik orqali investitsiyalarni qoplash uchun zarur bo'lgan yillar sonini aks ettiradi. Barqaror koeffitsiyent biznesning fundamental chidamliligini va uzoq muddatli bozor konsensusini tasdiqlaydi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati dexcom.com DXCM|Narx-foyda koeffitsiyenti NOVT (Novanta)|P/E multiplikatori Haemonetics Corp (HAE)|Inspire Sleep - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati PRCT (Procept)|CONMED Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati pulsebiosciences.com PLSE|INMD: P/E multiplikatori|Narx-foyda koeffitsiyenti Picard Medical Corp|Narx-foyda koeffitsiyenti SRDX|SENS: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NeuroPace, Inc. (NPCE)|Narx-foyda koeffitsiyenti tactilemedical.com TCMD|P/E multiplikatori SNWV (SANUWAVE)|Outset Medical Inc (OM) - Kapitalizatsiyaning foydaga nisbati|Electromed Inc - P/E multiplikatori|LNSR (LENSAR Inc) - Narx-foyda multiplikatori|RCEL: P/E multiplikatori|PROF - Biznesning o‘zini qoplash muddati|BDMD (Baird Medical Investment Holdings) - P/E multiplikatori|Narx-foyda koeffitsiyenti EDAP Medical (EDAP)|P/E multiplikatori APYX|P/E multiplikatori icecure-medical.com (ICCM)|Narxning foydaga nisbati Pulmonx LUNG|TELA Bio Inc. - Narxning foydaga nisbati|CTSO: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SRTS (Sensus Healthcare Inc)|ZYXI: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati electroCore (ECOR)|Narxning foydaga nisbati Vicarious Surgical Inc|IINN - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narx-foyda koeffitsiyenti ICU (SeaStar Medical)|P/E multiplikatori iridex.com (IRIX)|P/E multiplikatori INBS (Intelligent Bio Solutions Inc.)|Biznesning o‘zini qoplash muddati Beyond Air Inc (XAIR)|PFSA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati SSKN|GlucoTrack, Inc. (GCTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti nanovibronix.com|VERO (Venus Concept Corp) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nuwellis Corp NUWE|Narxning foydaga nisbati Aethlon Medical (AEMD)|asensus.com - Narx-foyda multiplikatori|Avinger - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati BSGM (Biosig Technologies)|CUTR - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati KNW|NARI: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati nevro.com (NVRO)|Narxning foydaga nisbati ReShape Lifesciences, Inc.|Narx-foyda multiplikatori SILK (Silk Road Medical, Inc.)